This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly ...

Last summer, scientists at the University of Oxford launched a clinical trial of a combined RSV and hMPV vaccine in partnership with Moderna, and Andrew Pollard, a professor of infection and ...

Most children have had HMPV by the time they reach the age of ... There’s currently no cure or vaccine for the disease, though Moderna, the maker of a COVID-19 vaccine, is working to produce ...

According to the NAID, Moderna, the manufacturer of the Covid-19 vaccine, has just ended an early trial of an mRNA vaccine against HMPV and parainfluenza. According to respiratory virus ...

According to the NAID, Moderna, the manufacturer of the Covid-19 vaccine, has just ended an early trial of an mRNA vaccine against HMPV and parainfluenza. According to respiratory virus surveillance ...

Another Moderna vaccine, mRNA-1653, simultaneously targets human metapneumovirus (HMPV) and parainfluenza virus (PIV3). These viruses typically cause mild respiratory illness, but symptoms can ...